SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-214797
Filing Date
2018-07-09
Accepted
2018-07-09 17:11:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d669553dsc13d.htm SC 13D 58257
  Complete submission text file 0001193125-18-214797.txt   59519
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Subject) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90473 | Film No.: 18945330
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER CA 08807
Business Address
Patel Chintu (Filed by) CIK: 0001737428 (see all company filings)

Type: SC 13D